Search
for
Sort by
Research 30 of 352
- Recurrence of Alopecia Areata in a Patient Receiving Etanercept Injections
- Onset of lichen planopilaris during treatment with etanercept
- Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau
- Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept
- Psoriatic onychopachydermoperiostitis: improvement with etanercept
- Acrodermatitis continua resistant to etanercept: Therapeutic challenge and Unfortunate outcome
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Severe cutaneous adverse reactions to drugs
- Safety of dermatologic medications in pregnancy and lactation
- Drugs and Hair Loss
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- Alopecia universalis during treatment with leflunomide and adalimumab - Case report
- Trichorrhexis nodosa: a distinctive presentation after tumour necrosis factor-α inhibitor therapy
- Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
- Novel therapies for alopecia areata: The era of rational drug development
- Innovative Therapeutics in Pediatric Dermatology
- Successful rapid subcutaneous desensitization to anakinra in a case of delayed‐type hypersensitivity reaction
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- Ottawa, Ontario, Canada, February 13–16, 2013
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- British Association of Dermatologists centenary year: standing on the shoulders of giants
- Current systemic treatment strategies for hidradenitis suppurativa
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice